Literature DB >> 23885323

SOCS proteins in development and disease.

Monique C Trengove1, Alister C Ward.   

Abstract

Cytokine and growth factor signaling mediates essential roles in the differentiation, proliferation, survival and function of a number of cell lineages. This is achieved via specific receptors located on the surface of target cells, with ligand binding activating key intracellular signal transduction cascades to mediate the requisite cellular outcome. Effective resolution of receptor signaling is also essential, with excessive signaling having the potential for pathological consequences. The Suppressor of cytokine signaling (SOCS) family of proteins represent one important mechanism to extinguish cytokine and growth factor receptor signaling. There are 8 SOCS proteins in mammals; SOCS1-7 and the alternatively named Cytokine-inducible SH2-containing protein (CISH). SOCS1-3 and CISH are predominantly associated with the regulation of cytokine receptor signaling, while SOCS4-7 are more commonly involved in the control of Receptor tyrosine kinase (RTK) signaling. Individual SOCS proteins are typically induced by specific cytokines and growth factors, thereby generating a negative feedback loop. As a consequence of their regulatory properties, SOCS proteins have important functions in development and homeostasis, with increasing recognition of their role in disease, particularly their tumor suppressor and anti-inflammatory functions. This review provides a synthesis of our current understanding of the SOCS family, with an emphasis on their immune and hematopoietic roles.

Entities:  

Keywords:  JAK-STAT; SOCS; cytokine; development; disease; growth factor; immunity; receptor tyrosine; signalling

Year:  2013        PMID: 23885323      PMCID: PMC3714205     

Source DB:  PubMed          Journal:  Am J Clin Exp Immunol


  259 in total

1.  Twenty proteins containing a C-terminal SOCS box form five structural classes.

Authors:  D J Hilton; R T Richardson; W S Alexander; E M Viney; T A Willson; N S Sprigg; R Starr; S E Nicholson; D Metcalf; N A Nicola
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

2.  Induction of JAB/SOCS-1/SSI-1 and CIS3/SOCS-3/SSI-3 is involved in gp130 resistance in cardiovascular system in rat treated with cardiotrophin-1 in vivo.

Authors:  I Hamanaka; Y Saito; H Yasukawa; I Kishimoto; K Kuwahara; Y Miyamoto; M Harada; E Ogawa; N Kajiyama; N Takahashi; T Izumi; R Kawakami; I Masuda; A Yoshimura; K Nakao
Journal:  Circ Res       Date:  2001-04-13       Impact factor: 17.367

3.  Lack of Socs2 expression causes the high-growth phenotype in mice.

Authors:  S Horvat; J F Medrano
Journal:  Genomics       Date:  2001-03-01       Impact factor: 5.736

4.  JAB/SOCS1/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling.

Authors:  B Sporri; P E Kovanen; A Sasaki; A Yoshimura; W J Leonard
Journal:  Blood       Date:  2001-01-01       Impact factor: 22.113

Review 5.  Cell signaling by receptor tyrosine kinases.

Authors:  Mark A Lemmon; Joseph Schlessinger
Journal:  Cell       Date:  2010-06-25       Impact factor: 41.582

6.  The SOCS-1 gene methylation in chronic myeloid leukemia patients.

Authors:  Ozden Hatirnaz; Umit Ure; Cem Ar; Cemaliye Akyerli; Teoman Soysal; Burhan Ferhanoğlu; Tayfun Ozçelik; Ugur Ozbek
Journal:  Am J Hematol       Date:  2007-08       Impact factor: 10.047

7.  Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancer.

Authors:  Walid Sasi; Wen G Jiang; Anup Sharma; Kefah Mokbel
Journal:  BMC Cancer       Date:  2010-04-30       Impact factor: 4.430

8.  SOCS3 promotes TLR4 response in macrophages by feedback inhibiting TGF-beta1/Smad3 signaling.

Authors:  Xia Liu; Yongliang Zhang; Yizhi Yu; Xiao Yang; Xuetao Cao
Journal:  Mol Immunol       Date:  2007-10-24       Impact factor: 4.407

9.  Combined hypermethylation and chromosome loss associated with inactivation of SSI-1/SOCS-1/JAB gene in human hepatocellular carcinomas.

Authors:  Hisaki Nagai; Yong Sung Kim; Noboru Konishi; Masaru Baba; Takeo Kubota; Akihiko Yoshimura; Mitsuru Emi
Journal:  Cancer Lett       Date:  2002-12-01       Impact factor: 8.679

10.  Suppressor of cytokine signaling 3 regulates CD8 T-cell proliferation by inhibition of interleukins 6 and 27.

Authors:  Christine Brender; Gillian M Tannahill; Brendan J Jenkins; Joel Fletcher; Ruth Columbus; Christiaan J M Saris; Matthias Ernst; Nicos A Nicola; Douglas J Hilton; Warren S Alexander; Robyn Starr
Journal:  Blood       Date:  2007-07-03       Impact factor: 22.113

View more
  73 in total

1.  Bromodomain and Extraterminal Inhibition by JQ1 Produces Divergent Transcriptional Regulation of Suppressors of Cytokine Signaling Genes in Adipocytes.

Authors:  Paula Mota de Sá; Allison J Richard; Jacqueline M Stephens
Journal:  Endocrinology       Date:  2020-02-01       Impact factor: 4.736

2.  Expression of suppressor of cytokine signaling genes in human elderly and Alzheimer's disease brains and human microglia.

Authors:  D G Walker; A M Whetzel; L-F Lue
Journal:  Neuroscience       Date:  2014-10-05       Impact factor: 3.590

3.  Suppressor of Cytokine Signaling-1 Peptidomimetic Limits Progression of Diabetic Nephropathy.

Authors:  Carlota Recio; Iolanda Lazaro; Ainhoa Oguiza; Laura Lopez-Sanz; Susana Bernal; Julia Blanco; Jesus Egido; Carmen Gomez-Guerrero
Journal:  J Am Soc Nephrol       Date:  2016-09-08       Impact factor: 10.121

Review 4.  TLR2 and TLR4 in autoimmune diseases: a comprehensive review.

Authors:  Yu Liu; Heng Yin; Ming Zhao; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

5.  Lineage-Specific and Non-specific Cytokine-Sensing Genes Respond Differentially to the Master Regulator STAT5.

Authors:  Xianke Zeng; Michaela Willi; Ha Youn Shin; Lothar Hennighausen; Chaochen Wang
Journal:  Cell Rep       Date:  2016-12-20       Impact factor: 9.423

6.  KIAA0317 regulates pulmonary inflammation through SOCS2 degradation.

Authors:  Travis B Lear; Alison C McKelvey; John W Evankovich; Shristi Rajbhandari; Tiffany A Coon; Sarah R Dunn; James D Londino; Bryan J McVerry; Yingze Zhang; Eleanor Valenzi; Christine L Burton; Rachael Gordon; Sebastien Gingras; Karina C Lockwood; Michael J Jurczak; Robert Lafyatis; Mark J Shlomchik; Yuan Liu; Bill B Chen
Journal:  JCI Insight       Date:  2019-10-03

7.  SOCS2 polymorphisms are not associated with clinical and biochemical phenotypes in acromegalic patients.

Authors:  Ericka B Trarbach; Alexander A Jorge; Felipe H Duarte; Marcello D Bronstein; Raquel S Jallad
Journal:  Pituitary       Date:  2017-06       Impact factor: 4.107

8.  MicroRNA-155 may be involved in the pathogenesis of atopic dermatitis by modulating the differentiation and function of T helper type 17 (Th17) cells.

Authors:  L Ma; H-B Xue; F Wang; C-M Shu; J-H Zhang
Journal:  Clin Exp Immunol       Date:  2015-05-25       Impact factor: 4.330

9.  Retinal Axon Guidance Requires Integration of Eya and the Jak/Stat Pathway into Phosphotyrosine-Based Signaling Circuitries in Drosophila.

Authors:  Charlene S L Hoi; Wenjun Xiong; Ilaria Rebay
Journal:  Genetics       Date:  2016-05-18       Impact factor: 4.562

10.  Suppressor of Cytokine Signaling (SOCS)1 Regulates Interleukin-4 (IL-4)-activated Insulin Receptor Substrate (IRS)-2 Tyrosine Phosphorylation in Monocytes and Macrophages via the Proteasome.

Authors:  Sarah M McCormick; Nagaraj Gowda; Jessie X Fang; Nicola M Heller
Journal:  J Biol Chem       Date:  2016-08-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.